Molina Healthcare, Inc $MOH Shares Acquired by Chemistry Wealth Management LLC

Key Points

• Chemistry Wealth Management increased its Molina Healthcare stake by 52.5% in the second quarter, bringing its holdings to 15,517 shares valued at approximately $3.55 million. Institutional investors collectively own 98.5% of the company.
• Analyst sentiment remains mixed but leans toward “Hold,” with a consensus price target of $202.44. Ratings include one Strong Buy, three Buys, eleven Holds, and two Sells.
• Molina Healthcare exceeded quarterly earnings expectations, reporting $1.51 in EPS versus a $1.39 estimate and $10.87 billion in revenue. However, revenue declined 4.8% year over year, and insiders recently sold shares.

Chemistry Wealth Management LLC grew its stake in Molina Healthcare, Inc (NYSE:MOH - Free Report) by 52.5% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 15,517 shares of the company's stock after acquiring an additional 5,339 shares during the period. Chemistry Wealth Management LLC's holdings in Molina Healthcare were worth $3,549,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently added to or reduced their stakes in MOH. 7G Capital Management LLC purchased a new position in Molina Healthcare during the 4th quarter valued at about $1,735,000. BNP Paribas Financial Markets grew its position in Molina Healthcare by 63.0% in the 4th quarter. BNP Paribas Financial Markets now owns 439,371 shares of the company's stock valued at $76,248,000 after acquiring an additional 169,739 shares in the last quarter. M&T Bank Corp increased its stake in Molina Healthcare by 451.1% during the fourth quarter. M&T Bank Corp now owns 42,455 shares of the company's stock worth $7,368,000 after purchasing an additional 34,751 shares during the period. Aurora Investment Managers LLC. purchased a new stake in Molina Healthcare during the first quarter worth about $2,349,000. Finally, Nations Financial Group Inc. IA ADV acquired a new stake in shares of Molina Healthcare during the fourth quarter worth about $1,277,000. Institutional investors and hedge funds own 98.50% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the stock. Bank of America raised shares of Molina Healthcare from an "underperform" rating to a "buy" rating and set a $250.00 target price on the stock in a research note on Wednesday, April 29th. Morgan Stanley upped their price objective on Molina Healthcare from $146.00 to $167.00 and gave the stock an "equal weight" rating in a research report on Thursday, June 4th. Wall Street Zen upgraded Molina Healthcare from a "sell" rating to a "hold" rating in a report on Saturday, May 2nd. Deutsche Bank Aktiengesellschaft reissued a "hold" rating and set a $129.00 target price on shares of Molina Healthcare in a research note on Friday, April 24th. Finally, UBS Group increased their price target on Molina Healthcare from $180.00 to $202.00 and gave the company a "neutral" rating in a research report on Friday, May 22nd. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, eleven have assigned a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, Molina Healthcare presently has an average rating of "Hold" and a consensus target price of $202.44.

Insider Transactions at Molina Healthcare

In other news, CAO Maurice Hebert sold 600 shares of the stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $191.55, for a total value of $114,930.00. Following the transaction, the chief accounting officer owned 12,815 shares in the company, valued at approximately $2,454,713.25. This represents a 4.47% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Jeff D. Barlow sold 17,811 shares of the firm's stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $186.12, for a total value of $3,314,983.32. Following the sale, the insider directly owned 67,175 shares in the company, valued at $12,502,611. This trade represents a 20.96% decrease in their position. The disclosure for this sale is available in the SEC filing. 1.44% of the stock is owned by insiders.

Molina Healthcare Price Performance

Shares of MOH opened at $196.65 on Friday. The firm has a market capitalization of $10.27 billion, a price-to-earnings ratio of -1,092.43, a PEG ratio of 28.14 and a beta of 0.75. The firm's fifty day simple moving average is $209.25 and its 200-day simple moving average is $177.81. Molina Healthcare, Inc has a twelve month low of $121.06 and a twelve month high of $244.89. The company has a current ratio of 1.68, a quick ratio of 1.68 and a debt-to-equity ratio of 0.95.

Molina Healthcare (NYSE:MOH - Get Free Report) last issued its earnings results on Wednesday, July 22nd. The company reported $1.51 EPS for the quarter, topping analysts' consensus estimates of $1.39 by $0.12. The firm had revenue of $10.87 billion during the quarter, compared to the consensus estimate of $10.83 billion. Molina Healthcare had a negative net margin of 0.02% and a positive return on equity of 3.73%. The company's revenue was down 4.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $5.48 earnings per share. Equities analysts forecast that Molina Healthcare, Inc will post 5.29 EPS for the current fiscal year.

Molina Healthcare Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source